Richa Thakur, MD (@richathakurmd) 's Twitter Profile
Richa Thakur, MD

@richathakurmd

Palliative Care Physician, Polyglot, Aspiring Oncologist

ID: 1410955774189318144

calendar_today02-07-2021 13:37:38

240 Tweet

256 Followers

593 Following

Rahul Banerjee, MD, FACP (@rahulbanerjeemd) 's Twitter Profile Photo

🎵 Orva-cel, oh orva-cel, what would your long-term data be? (Sung to 🌲 tune) Now we know! Excellent @BloodJournal paper by Andrew Portuguese Mazyar Shadman, MD MPH et al about humanized BCMA CAR-T in #MMsm when it was still Fred Hutch Cancer Center concept. Very similar to what became JCARH125…

Dr Joseph McCollom DO (@realbowtiedoc) 's Twitter Profile Photo

Nothing gives me a boost like meeting with my ASCO PallOnc Community of Practice family. Combine that with my love of #nerdy 🤓 and this is going to be a dynamite collaboration. Make sure you don't miss out next week. Join us! #hpm #hapc #pallonc #supponc #AI #healthIT Danijela Jakovljevic Richa Thakur, MD

Ajay Major, MD, MBA (@majorajay) 's Twitter Profile Photo

We are seeking patients with relapsed or refractory FL or DLBCL for a compensated study about experiences with bispecific antibody therapies. To my #lymsm & #onctwitter colleagues: please share the attached flyer with your networks. Thank you! #tcellrx

We are seeking patients with relapsed or refractory FL or DLBCL for a compensated study about experiences with bispecific antibody therapies. To my #lymsm & #onctwitter colleagues: please share the attached flyer with your networks. Thank you! #tcellrx
Arthur Aung (@arthur_aung) 's Twitter Profile Photo

So excited to be part of the GRACE family! I am looking forward to learning and working together to help advance patient education and advocacy in lung cancer.

Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

Just out! Latest NCCN guidelines has added daratumumab as Category 1 recommendation for high risk smoldering myeloma. In AQUILA trial, daratumumab: -Delayed progression to active myeloma -Delayed time to needing full myeloma therapy -Better overall survival

Just out! Latest NCCN guidelines has added daratumumab as Category 1 recommendation for high risk smoldering myeloma.  

In AQUILA trial, daratumumab:

-Delayed progression to active myeloma
-Delayed time to needing full myeloma therapy 
-Better overall survival
Rahul Banerjee, MD, FACP (@rahulbanerjeemd) 's Twitter Profile Photo

Great Blood Cancer Journal RW data from US #MMsm consortium, led by Danai Dima Leyla Shune MD et al! BCMA bsAbs can work in BCMA-exposed. While we await better predictive tools, time & type of prior therapy matters: - ⬆️ PFS if > 9 months since prior BCMA - ⬇️ PFS if prior BCMA was bsAb

Great <a href="/BloodCancerJnl/">Blood Cancer Journal</a> RW data from US #MMsm consortium, led by <a href="/DimaDanai/">Danai Dima</a> <a href="/leshune/">Leyla Shune MD</a> et al!

BCMA bsAbs can work in BCMA-exposed. While we await better predictive tools, time &amp; type of prior therapy matters:
 - ⬆️ PFS if &gt; 9 months since prior BCMA
 - ⬇️ PFS if prior BCMA was bsAb
OncoDaily (@oncodaily) 's Twitter Profile Photo

Fred Hutch Cancer Center is Seeking a Clinician Scholar in Multiple Myeloma - Mazyar Shadman Mazyar Shadman, MD MPH Fred Hutch Cancer Center oncodaily.com/blog/mazyar-sh… #Cancer #Medicine #Health #Myeloma #Job #MedX #MedNews #MedEd #Oncology #OncoDaily

Fred Hutch Cancer Center is Seeking a Clinician Scholar in Multiple Myeloma - Mazyar Shadman
<a href="/mshadman/">Mazyar Shadman, MD MPH</a> <a href="/fredhutch/">Fred Hutch Cancer Center</a> 

oncodaily.com/blog/mazyar-sh…

#Cancer #Medicine #Health #Myeloma #Job #MedX #MedNews #MedEd #Oncology #OncoDaily
Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

What I have been worried about. We now spend more on health care than groceries or housing. And it’s not going to slow down. See Thread. nytimes.com/interactive/20…

What I have been worried about.  

We now spend more on health care than groceries or housing. And it’s not going to slow down. 
See Thread. 
nytimes.com/interactive/20…
Richa Thakur, MD (@richathakurmd) 's Twitter Profile Photo

I will be speaking at the IMF MCW in Seattle on 8/9! Join me and other #myeloma community members to learn all about MM—an intro to the disease, upfront treatments at diagnosis, maintenance therapy, managing side effects, Q&A, & more. Register now: mmsm.link/44mmIKh

I will be speaking at the IMF MCW in Seattle on 8/9! Join me and other #myeloma community
members to learn all about MM—an intro to the disease, upfront treatments at diagnosis,
maintenance therapy, managing side effects, Q&amp;A, &amp; more. Register now:
mmsm.link/44mmIKh
International Myeloma Foundation (@imfmyeloma) 's Twitter Profile Photo

What is palliative care for multiple myeloma—and why is it so important? Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, explains the role of palliative care in this short clip. #AsktheIMF #mmsm #palliativecare

Samer Al Hadidi, MD,MS,FACP (@hadidisamer) 's Twitter Profile Photo

Join HealthTree Foundation Webinar: Can You Stop Myeloma Treatment and Still Stay in Remission? #mmsm UAMS Myeloma Center 🕣 Jul 29, 2025 / 01:00PM - 02:00PM EDT ➡️ healthtree.org/myeloma/commun… Will be sharing some long term data as well as if this is possible, there will be room for questions

Join <a href="/HealthTree/">HealthTree Foundation</a> Webinar: Can You Stop Myeloma Treatment and Still Stay in Remission? #mmsm <a href="/UAMSMyeloma/">UAMS Myeloma Center</a> 

🕣 Jul 29, 2025 / 01:00PM - 02:00PM EDT

➡️ healthtree.org/myeloma/commun…

Will be sharing some long term data as well as if this is possible, there will be room for questions